Collector
Eli Lilly to acquire Boston biotech Kelonia Therapy in $7 billion deal | Collector
Eli Lilly to acquire Boston biotech Kelonia Therapy in $7 billion deal
Boston.com

Eli Lilly to acquire Boston biotech Kelonia Therapy in $7 billion deal

The purchase marks the pharmaceutical giant’s latest multibillion-dollar move to expand its footprint in Massachusetts. The post Eli Lilly to acquire Boston biotech Kelonia Therapy in $7 billion deal appeared first on Boston.com .

Go to News Site